{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:13:54Z","timestamp":1793142834304,"version":"4.5.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SCHU 2983\/1-1"],"award-info":[{"award-number":["SCHU 2983\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SCHU 2983\/2-1"],"award-info":[{"award-number":["SCHU 2983\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FS\/16\/32\/32184"],"award-info":[{"award-number":["FS\/16\/32\/32184"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010447","name":"Deutsches Zentrum f\u00fcr Herz-Kreislaufforschung","doi-asserted-by":"publisher","award":["81Z0710102"],"award-info":[{"award-number":["81Z0710102"]}],"id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RG\/16\/14\/32397"],"award-info":[{"award-number":["RG\/16\/14\/32397"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["CH\/16\/3\/32406"],"award-info":[{"award-number":["CH\/16\/3\/32406"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015544","name":"King\u2019s College Hospital Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009360","name":"King\u2019s College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009360","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.molmed.2020.02.001","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T17:45:57Z","timestamp":1584035157000},"page":"583-596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Noncoding RNAs versus Protein Biomarkers in Cardiovascular Disease"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2643-7345","authenticated-orcid":false,"given":"Christian","family":"Schulte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temo","family":"Barwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0597-829X","authenticated-orcid":false,"given":"Manuel","family":"Mayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2020.02.001_bb0005","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.molmed.2020.02.001_bb0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.molmed.2020.02.001_bb0015","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/0022-2828(89)90680-9","article-title":"Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients","volume":"21","author":"Katus","year":"1989","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.molmed.2020.02.001_bb0020","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.jacc.2016.10.020","article-title":"High-sensitivity cardiac troponin, statin therapy, and risk of coronary heart disease","volume":"68","author":"Ford","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.molmed.2020.02.001_bb0025","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1056\/NEJMoa1803377","article-title":"Application of high-sensitivity troponin in suspected myocardial infarction","volume":"380","author":"Neumann","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2020.02.001_bb0030","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/eurheartj\/ehw172","article-title":"Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium","volume":"37","author":"Blankenberg","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.molmed.2020.02.001_bb0035","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1039\/C004495D","article-title":"Proteome-wide protein concentrations in the human heart","volume":"6","author":"Aye","year":"2010","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.molmed.2020.02.001_bb0040","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1074\/mcp.M900176-MCP200","article-title":"Identification of cardiac myosin-binding protein C as a candidate biomarker of myocardial infarction by proteomics analysis","volume":"8","author":"Jacquet","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.molmed.2020.02.001_bb0045","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.117.028084","article-title":"Direct comparison of cardiac myosin-binding protein C with cardiac troponins for the early diagnosis of acute myocardial infarction","volume":"136","author":"Kaier","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2020.02.001_bb0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00395-015-0478-5","article-title":"Cardiac myosin-binding protein C: a potential early biomarker of myocardial injury","volume":"110","author":"Baker","year":"2015","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.molmed.2020.02.001_bb0055","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/CIRCRESAHA.119.314937","article-title":"Comparative analysis of circulating noncoding RNAs versus protein biomarkers in the detection of myocardial injury","volume":"125","author":"Schulte","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.02.001_bb0060","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1136\/heartjnl-2017-312257","article-title":"Cardiac myosin-binding protein C is a novel marker of myocardial injury and fibrosis in aortic stenosis","volume":"104","author":"Anand","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.molmed.2020.02.001_bb0065","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008108","article-title":"Protein biomarkers of cardiovascular disease and mortality in the community","volume":"7","author":"Ho","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.molmed.2020.02.001_bb0070","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","article-title":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily","volume":"94","author":"Bootcov","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.02.001_bb0075","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.atherosclerosis.2018.12.009","article-title":"Growth differentiation factor-15 regulates oxLDL-induced lipid homeostasis and autophagy in human macrophages","volume":"281","author":"Ackermann","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.molmed.2020.02.001_bb0080","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1373\/clinchem.2012.190322","article-title":"Clinical and genetic correlates of growth differentiation factor 15 in the community","volume":"58","author":"Ho","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.molmed.2020.02.001_bb0085","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/CIRCULATIONAHA.106.650846","article-title":"Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome","volume":"115","author":"Wollert","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2020.02.001_bb0090","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/eurheartj\/ehm465","article-title":"Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction","volume":"28","author":"Kempf","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.molmed.2020.02.001_bb0095","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCGENETICS.108.824870","article-title":"Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study","volume":"2","author":"Kempf","year":"2009","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.molmed.2020.02.001_bb0100","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.109.928846","article-title":"Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial","volume":"122","author":"Anand","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2020.02.001_bb0105","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.arr.2018.07.004","article-title":"Towards frailty biomarkers: candidates from genes and pathways regulated in aging and age-related diseases","volume":"47","author":"Cardoso","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.molmed.2020.02.001_bb0110","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jacc.2019.01.018","article-title":"B-type natriuretic peptide during treatment with sacubitril\/valsartan","volume":"73","author":"Myhre","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.molmed.2020.02.001_bb0115","article-title":"Circulating biomarkers for long-term cardiovascular risk stratification in apparently healthy individuals from the MONICA 10 cohort","author":"Frary","year":"2019","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.molmed.2020.02.001_bb0120","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/CIRCULATIONAHA.118.036349","article-title":"High-frequency biomarker measurements of troponin, NT-proBNP, and C-reactive protein for prediction of new coronary events after acute coronary syndrome","volume":"139","author":"Oemrawsingh","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2020.02.001_bb0125","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2020.02.001_bb0130","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCULATIONAHA.117.029882","volume":"137","author":"Stienen","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2020.02.001_bb0135","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2020.02.001_bb0140","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2020.02.001_bb0145","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","volume":"33","author":"Perk","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.molmed.2020.02.001_bb0150","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12881-019-0910-z","article-title":"Association of high sensitive C-reactive protein with coronary heart disease: a Mendelian randomization study","volume":"20","author":"Zhuang","year":"2019","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.molmed.2020.02.001_bb0155","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1172\/JCI86924","article-title":"Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques","volume":"127","author":"Langley","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2020.02.001_bb0160","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrm.2017.104","article-title":"The functions and unique features of long intergenic non-coding RNA","volume":"19","author":"Ransohoff","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2020.02.001_bb0165","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cell.2017.01.019","article-title":"UV irradiation induces a non-coding RNA that functionally opposes the protein encoded by the same gene","volume":"168","author":"Williamson","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2020.02.001_bb0170","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/aps.2018.35","article-title":"The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases","volume":"39","author":"E, S.","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.molmed.2020.02.001_bb0175","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/CIRCRESAHA.119.315455","article-title":"MicroRNAs as companion biomarkers for the diagnosis and prognosis of acute coronary syndromes","volume":"125","author":"Condorelli","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.02.001_bb0180","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1093\/eurheartj\/ehu151","article-title":"Assessment of microRNAs in patients with unstable angina pectoris","volume":"35","author":"Zeller","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.molmed.2020.02.001_bb0185","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.02.001_bb0190","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.02.001_bb0195","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2020.02.001_bb0200","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1093\/nar\/gkr254","article-title":"Characterization of extracellular circulating microRNA","volume":"39","author":"Turchinovich","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2020.02.001_bb0205","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature07242","article-title":"The impact of microRNAs on protein output","volume":"455","author":"Baek","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2020.02.001_bb0210","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.critrevonc.2010.11.004","article-title":"Circulating microRNAs: association with disease and potential use as biomarkers","volume":"80","author":"Reid","year":"2011","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.molmed.2020.02.001_bb0215","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.molmed.2014.10.006","article-title":"miRNAs as biomarkers of myocardial infarction: a step forward towards personalized medicine?","volume":"20","author":"Goretti","year":"2014","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molmed.2020.02.001_bb0220","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11883-015-0548-z","article-title":"MicroRNA biomarkers for coronary artery disease?","volume":"17","author":"Kaudewitz","year":"2015","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.molmed.2020.02.001_bb0225","doi-asserted-by":"crossref","first-page":"18255","DOI":"10.1073\/pnas.0608791103","article-title":"A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure","volume":"103","author":"van Rooij","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.02.001_bb0230","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1073\/pnas.0805038105","article-title":"Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis","volume":"105","author":"van Rooij","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.02.001_bb0235","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/eurheartj\/ehq013","article-title":"Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans","volume":"31","author":"Wang","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.molmed.2020.02.001_bb0240","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jacc.2013.05.025","article-title":"Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy","volume":"62","author":"Liebetrau","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.molmed.2020.02.001_bb0245","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1160\/TH13-05-0368","article-title":"Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery disease","volume":"110","author":"Kaudewitz","year":"2013","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.molmed.2020.02.001_bb0250","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1373\/clinchem.2017.284653","article-title":"Endogenous heparin interferes with quantification of microRNAs by RT-qPCR","volume":"64","author":"Boileau","year":"2018","journal-title":"Clin. Chem."},{"key":"10.1016\/j.molmed.2020.02.001_bb0255","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1055\/s-0038-1660437","article-title":"Overcoming heparin-associated RT-qPCR inhibition and normalization issues for microRNA quantification in patients with acute myocardial infarction","volume":"118","author":"Coelho-Lima","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.molmed.2020.02.001_bb0260","doi-asserted-by":"crossref","first-page":"154157","DOI":"10.1016\/j.cyto.2017.09.013","article-title":"Platelet-derived chemokines in inflammation and atherosclerosis","volume":"122","author":"Bakogiannis","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.molmed.2020.02.001_bb0265","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/cvr\/cvz070","article-title":"Platelets in cardiac ischaemia\/reperfusion injury \u2013 a promising therapeutic target","volume":"115","author":"Ziegler","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.molmed.2020.02.001_bb0270","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001249","article-title":"MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease","volume":"3","author":"Jansen","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.molmed.2020.02.001_bb0275","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jacc.2012.03.056","article-title":"Prospective study on circulating microRNAs and risk of myocardial infarction","volume":"60","author":"Zampetaki","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.molmed.2020.02.001_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145930","article-title":"miRNA-197 and miRNA-223 predict cardiovascular death in a cohort of patients with symptomatic coronary artery disease","volume":"10","author":"Schulte","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2020.02.001_bb0285","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.yjmcc.2016.05.009","article-title":"Circulating microRNAs predict future fatal myocardial infarction in healthy individuals \u2013 the HUNT study","volume":"97","author":"Bye","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.molmed.2020.02.001_bb0290","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCRESAHA.116.308434","article-title":"Circulating noncoding RNAs as biomarkers of cardiovascular disease and injury","volume":"120","author":"Viereck","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.02.001_bb0295","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1101\/gr.132159.111","article-title":"The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression","volume":"22","author":"Derrien","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.molmed.2020.02.001_bb0300","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/CIRCRESAHA.114.303915","article-title":"Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure","volume":"114","author":"Kumarswamy","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.02.001_bb0305","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1101\/gad.1800909","article-title":"Long noncoding RNAs: functional surprises from the RNA world","volume":"23","author":"Wilusz","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2020.02.001_bb0310","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ajh\/hpx197","article-title":"Noncoding RNAs in cardiovascular disease: pathological relevance and emerging role as biomarkers and therapeutics","volume":"31","author":"Gangwar","year":"2018","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.molmed.2020.02.001_bb0315","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.117.028398","article-title":"Long noncoding RNAs and angiogenesis: regulatory information for chromatin remodeling","volume":"136","author":"Zampetaki","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2020.02.001_bb0320","first-page":"e22","article-title":"Response by Schulte et al to letter regarding article, \u201ccomparative analysis of circulating noncoding RNAs versus protein biomarkers in the detection of myocardial injury.\u201d","volume":"125","author":"Schulte","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.02.001_bb0325","doi-asserted-by":"crossref","first-page":"22384","DOI":"10.1038\/srep22384","article-title":"Reciprocal changes of circulating long non-coding RNAs ZFAS1 and CDR1AS predict acute myocardial infarction","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2020.02.001_bb0330","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1159\/000485588","article-title":"Circulating long noncoding RNA HOTAIR is an essential mediator of acute myocardial infarction","volume":"44","author":"Gao","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.molmed.2020.02.001_bb0335","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fphys.2019.00030","article-title":"Long non-coding RNAs: at the heart of cardiac dysfunction?","volume":"10","author":"Hobu\u00df","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.molmed.2020.02.001_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/atm.2016.06.06","article-title":"Prospective and therapeutic screening value of non-coding RNA as biomarkers in cardiovascular disease","volume":"4","author":"Busch","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.molmed.2020.02.001_bb0345","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nbt.2890","article-title":"Detecting and characterizing circular RNAs","volume":"32","author":"Jeck","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2020.02.001_bb0350","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency","volume":"495","author":"Memczak","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2020.02.001_bb0355","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.molcel.2013.08.017","article-title":"Circular intronic long noncoding RNAs","volume":"51","author":"Zhang","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2020.02.001_bb0360","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkl151","article-title":"Characterization of RNase R-digested cellular RNA source that consists of lariat and circular RNAs from pre-mRNA splicing","volume":"34","author":"Suzuki","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2020.02.001_bb0365","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/CIRCRESAHA.116.309568","article-title":"RBM20 regulates circular RNA production from the titin gene","volume":"119","author":"Khan","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.02.001_bb0370","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges","volume":"495","author":"Hansen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2020.02.001_bb0375","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.molcel.2017.02.017","article-title":"Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis","volume":"66","author":"Legnini","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2020.02.001_bb0380","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.molcel.2015.03.027","article-title":"Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed","volume":"58","author":"Rybak-Wolf","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2020.02.001_bb0385","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.molcel.2014.08.019","article-title":"circRNA biogenesis competes with pre-mRNA splicing","volume":"56","author":"Ashwal-Fluss","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2020.02.001_bb0390","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1242\/dev.128074","article-title":"Circular RNAs: analysis, expression and potential functions","volume":"143","author":"Barrett","year":"2016","journal-title":"Development"},{"key":"10.1016\/j.molmed.2020.02.001_bb0395","article-title":"A landscape of circular RNA expression in the human heart","volume":"113","author":"Tan","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.molmed.2020.02.001_bb0400","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1261\/rna.035667.112","article-title":"Circular RNAs are abundant, conserved, and associated with ALU repeats","volume":"19","author":"Jeck","year":"2013","journal-title":"RNA"},{"key":"10.1016\/j.molmed.2020.02.001_bb0405","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/cdd.2017.61","article-title":"Circular RNA mediates cardiomyocyte death via miRNA-dependent upregulation of MTP18 expression","volume":"24","author":"Wang","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.molmed.2020.02.001_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151753","article-title":"The circular RNA Cdr1as promotes myocardial infarction by mediating the regulation of miR-7a on its target genes expression","volume":"11","author":"Geng","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2020.02.001_bb0415","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jacc.2016.06.040","article-title":"Myocardial infarction-associated circular RNA predicting left ventricular dysfunction","volume":"68","author":"Vausort","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.molmed.2020.02.001_bb0420","first-page":"33","article-title":"The circular RNA MICRA for risk stratification after myocardial infarction","volume":"17","author":"Salgado-Somoza","year":"2017","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"10.1016\/j.molmed.2020.02.001_bb0425","doi-asserted-by":"crossref","first-page":"60280","DOI":"10.18632\/oncotarget.19941","article-title":"Circular RNAs promote TRPM3 expression by inhibiting hsa-miR-130a-3p in coronary artery disease patients","volume":"8","author":"Pan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.molmed.2020.02.001_bb0430","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1080\/10641963.2016.1273944","article-title":"Profiling and bioinformatics analyses reveal differential circular RNA expression in hypertensive patients","volume":"39","author":"Wu","year":"2017","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.molmed.2020.02.001_bb0435","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2337\/db16-0731","article-title":"Circulating microRNA-122 is associated with the risk of new-onset metabolic syndrome and type 2 diabetes","volume":"66","author":"Willeit","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.molmed.2020.02.001_bb0440","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2337\/dc16-1354","article-title":"Extracellular RNAs are associated with insulin resistance and metabolic phenotypes","volume":"40","author":"Shah","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmed.2020.02.001_bb0445","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1373\/clinchem.2017.285767","article-title":"Small ncRNA-Seq results of human tissues: variations depending on sample integrity","volume":"64","author":"Ludwig","year":"2018","journal-title":"Clin. Chem."},{"key":"10.1016\/j.molmed.2020.02.001_bb0450","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1038\/s41598-018-24531-8","article-title":"Regulatory T cell-derived extracellular vesicles modify dendritic cell function","volume":"8","author":"Tung","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2020.02.001_bb0455","first-page":"94","article-title":"The impact of hemolysis on cell-free microRNA biomarkers","volume":"4","author":"Kirschner","year":"2013","journal-title":"Front. Genet."},{"key":"10.1016\/j.molmed.2020.02.001_bb0460","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1373\/clinchem.2014.221341","article-title":"Circulating microRNA biomarker studies: pitfalls and potential solutions","volume":"61","author":"Witwer","year":"2015","journal-title":"Clin. Chem."},{"key":"10.1016\/j.molmed.2020.02.001_bb0465","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1373\/clinchem.2016.262824","article-title":"RT-qPCR and RT-digital PCR: a comparison of different platforms for the evaluation of residual disease in chronic myeloid leukemia","volume":"63","author":"Alikian","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.molmed.2020.02.001_bb0470","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0140-6736(94)92622-0","article-title":"Effect of heparin on polymerase chain reaction","volume":"343","author":"Satsangi","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2020.02.001_bb0475","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/CIRCRESAHA.116.309303","article-title":"MicroRNA biomarkers and platelet reactivity","volume":"120","author":"Sunderland","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.02.001_bb0480","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.molmed.2020.02.001_bb0485","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/nmeth.2697","article-title":"The need for transparency and good practices in the qPCR literature","volume":"10","author":"Bustin","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.molmed.2020.02.001_bb0490","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/01.CIR.83.3.1107","article-title":"Serum protein measurements and the diagnosis of acute myocardial infarction","volume":"83","author":"Ellis","year":"1991","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.molmed.2020.02.001_bb0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2006.02.056","article-title":"Biomarkers in acute cardiac disease. the present and the future","volume":"48","author":"Jaffe","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.molmed.2020.02.001_bb0500","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/01.CIR.88.2.750","article-title":"Biochemical markers of myocardial injury: is MB creatine kinase the choice for the 1990s?","volume":"88","author":"Adams","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2020.02.001_bb0505","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.119.042891","article-title":"A randomized trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: The Rapid Assessment of Possible Acute Coronary Syndrome in the Emergency Department With High-Sensitivity Troponin T Study (RAPID-TnT)","volume":"140","author":"Chew","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2020.02.001_bb0510","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbrc.2009.11.005","article-title":"Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction","volume":"391","author":"Ai","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2020.02.001_bb0515","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1373\/clinchem.2010.144121","article-title":"Plasma microRNA-499 as a biomarker of acute myocardial infarction","volume":"56","author":"Adachi","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.molmed.2020.02.001_bb0520","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1042\/CS20090645","article-title":"A translational study of circulating cell-free microRNA-1 in acute myocardial infarction","volume":"119","author":"Cheng","year":"2010","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.molmed.2020.02.001_bb0525","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1093\/eurheartj\/ehq167","article-title":"Circulating microRNAs are new and sensitive biomarkers of myocardial infarction","volume":"31","author":"D\u2019Alessandra","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.molmed.2020.02.001_bb0530","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/CIRCGENETICS.110.957415","article-title":"Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease","volume":"3","author":"Corsten","year":"2010","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.molmed.2020.02.001_bb0535","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1161\/CIRCULATIONAHA.111.037572","article-title":"Transcoronary concentration gradients of circulating microRNAs","volume":"124","author":"De Rosa","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2020.02.001_bb0540","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1161\/CIRCGENETICS.110.958975","article-title":"Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage","volume":"4","author":"Kuwabara","year":"2011","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.molmed.2020.02.001_bb0545","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1373\/clinchem.2011.173823","article-title":"Use of circulating microRNAs to diagnose acute myocardial infarction","volume":"58","author":"Devaux","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.molmed.2020.02.001_bb0550","doi-asserted-by":"crossref","first-page":"811","DOI":"10.7150\/ijbs.4439","article-title":"Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction","volume":"8","author":"Long","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.molmed.2020.02.001_bb0555","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/emmm.201201749","article-title":"Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs","volume":"4","author":"Oerlemans","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.molmed.2020.02.001_bb0560","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ijcard.2012.01.075","article-title":"Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction","volume":"167","author":"Olivieri","year":"2013","journal-title":"Int. J. Cardiol."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491420300459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491420300459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:51:53Z","timestamp":1778615513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491420300459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":112,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1471491420300459"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2020.02.001","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Noncoding RNAs versus Protein Biomarkers in Cardiovascular Disease","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2020.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}